Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP9 mRNA | CTD | PMID:36331819 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Zfp9 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP9 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP9 mRNA | CTD | PMID:32109520 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zfp9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP9 mRNA | CTD | PMID:19933214 and PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP9 mRNA | CTD | PMID:26377647 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Zfp9 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP9 mRNA | CTD | PMID:36041667 | 6-propyl-2-thiouracil | increases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ZFP9 mRNA | CTD | PMID:24780913 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ZNF25 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ZNF25 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF25 5' UTR | CTD | PMID:27901495 | bisphenol A | increases methylation | ISO | Zfp9 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of ZFP9 promoter | CTD | PMID:27312807 | bisphenol A | multiple interactions | ISO | Zfp9 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP9 mRNA | CTD | PMID:36041667 | bisphenol F | multiple interactions | ISO | Zfp9 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP9 mRNA | CTD | PMID:36041667 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ZNF25 mRNA | CTD | PMID:26079696 | cadmium dichloride | increases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of ZFP9 mRNA | CTD | PMID:25993096 | chlorpyrifos | decreases expression | ISO | Zfp9 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ZFP9 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP9 mRNA | CTD | PMID:20938992 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ZNF25 mRNA | CTD | PMID:20106945 more ... | dichloroacetic acid | decreases expression | ISO | Zfp9 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of ZFP9 mRNA | CTD | PMID:28962523 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZNF25 mRNA | CTD | PMID:29803840 | fluoranthene | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP9 mRNA | CTD | PMID:28329830 | folic acid | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP9 mRNA | CTD | PMID:20938992 | fulvestrant | increases methylation | EXP | | 6480464 | Fulvestrant results in increased methylation of ZNF25 gene | CTD | PMID:31601247 | furan | increases methylation | ISO | Zfp9 (Rattus norvegicus) | 6480464 | furan results in increased methylation of ZFP9 gene | CTD | PMID:22079235 | furan | decreases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | furan results in decreased expression of ZFP9 mRNA | CTD | PMID:25539665 | gentamycin | decreases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP9 mRNA | CTD | PMID:33387578 | inulin | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP9 mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP9 mRNA | CTD | PMID:20938992 | methylisothiazolinone | decreases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in decreased expression of ZNF25 mRNA | CTD | PMID:31629900 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ZNF25 mRNA | CTD | PMID:28001369 | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of ZNF25 mRNA | CTD | PMID:36318118 | paracetamol | affects expression | ISO | Zfp9 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ZFP9 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ZFP9 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP9 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP9 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of ZNF25 mRNA | CTD | PMID:36326898 | pirinixic acid | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZFP9 mRNA | CTD | PMID:19710929 | potassium dichromate | decreases expression | ISO | Zfp9 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of ZFP9 mRNA | CTD | PMID:23608068 | propiconazole | increases expression | ISO | Zfp9 (Mus musculus) | 6480464 | propiconazole results in increased expression of ZFP9 mRNA | CTD | PMID:21278054 | resveratrol | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ZFP9 mRNA] | CTD | PMID:31298478 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF25 mRNA | CTD | PMID:23557933 | silicon dioxide | increases expression | ISO | Zfp9 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of ZFP9 mRNA | CTD | PMID:23221170 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ZNF25 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of ZNF25 mRNA | CTD | PMID:31758290 | tetrachloromethane | increases expression | ISO | Zfp9 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ZFP9 mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | increases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of ZFP9 mRNA | CTD | PMID:31150632 | titanium dioxide | decreases expression | ISO | Zfp9 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ZFP9 mRNA | CTD | PMID:29128614 and PMID:29264374 | titanium dioxide | multiple interactions | ISO | Zfp9 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ZFP9 mRNA] | CTD | PMID:31298478 | titanium dioxide | increases expression | ISO | Zfp9 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ZFP9 mRNA | CTD | PMID:31298478 | trichloroethene | increases methylation | ISO | Zfp9 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of ZFP9 gene | CTD | PMID:27618143 | troglitazone | decreases expression | ISO | Zfp9 (Mus musculus) | 6480464 | troglitazone results in decreased expression of ZNF25 mRNA | CTD | PMID:28973697 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF25 mRNA | CTD | PMID:23179753 more ... | vinclozolin | decreases expression | ISO | Zfp9 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of ZFP9 mRNA | CTD | PMID:23034163 and PMID:23869203 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
